Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00049309 · ClinicalTrials.gov registry record · Phase 2
Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 161
- Enrollment target
NCT00049309 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 161 participants.
The verdict
NCT00049309, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 161 participants
- Enrollment target
Study Summary
RATIONALE: A diet that is low in fat and/or high in flaxseed may slow or prevent disease progression of prostate cancer. PURPOSE: Randomized phase II trial to study the effectiveness of a diet that is low in fat and/or high in flaxseed in slowing or preventing disease progression in patients who have newly diagnosed prostate cancer.
Interventions
- DIETARY_SUPPLEMENT dietary intervention
- DIETARY_SUPPLEMENT flaxseed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2003-01 |
| Est. Completion | 2006-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00049309
The ClinicalTrials.gov registry entry for NCT00049309 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which dietary intervention is the first listed.
NCT00049309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00049309 about?
NCT00049309 is a clinical study titled "Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer". RATIONALE: A diet that is low in fat and/or high in flaxseed may slow or prevent disease progression of prostate cancer. PURPOSE: Randomized phase II trial to study the effectiveness of a diet that is low in fat and/or high in flaxseed in slowing or preventing disease progression in patients who ha...
What is the current status of trial NCT00049309?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 161 participants. The study started on 2003-01. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00049309?
The interventions under investigation include: dietary intervention (DIETARY_SUPPLEMENT), flaxseed (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00049309?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.